Giant Cell Reparative Granuloma, a rare benign bone tumor in a child: case report
DOI:
https://doi.org/10.47456/rbps.v23isupl_1.36623Keywords:
Giant Cell Granuloma, Jaw, Maxillomandibular neoplasmsAbstract
Introduction: Giant Cell Reconstructive Granuloma (GCRG) is a rare and benign intraosseous tumor. It is unilateral and affects the mandible in the vast majority of cases, with variable clinical presentation resulting from tumor expansion. It has a good prognosis and there are no reports of metastatic lesions. Case report: A case study of a 6-year-old male, without comorbidities, with a rapidly growing bilateral tumor in the mandible (SIC). Hardened, painless lesion, without phlogistic signs, with bulging of the cheek mucosa and protuberances on the gingiva. He denied fever, weight loss, other symptoms or local trauma. Laboratory tests, serology, CT scans of the cervical, chest, abdomen and pelvis without alterations. Face tomography: expansive lesion remodeling the mandible with areas of continuity solution in the cortical bone, suggestive of fibrous dysplasia. Biopsy was performed showing GRCG. The GCRG corresponds to 7% of mandibular and maxillary tumors, of not yet fully defined etiology, usually observed after trauma and local inflammation, described as a reparative process resulting from possible intraosseous hemorrhage. More frequent in children and young adults, the clinic comes from intraosseous tumor expansion: compressive effects, facial asymmetry and dental deformities. Differential diagnoses include: giant cell tumor (GCT), aneurysmal bone cyst, fibrous dysplasia and the brown tumor. Its main differential diagnosis is GCT, a malignant tumor. Conclusion: Imaging exams help in the initial approach and the definitive diagnosis is through anatomic/histological study. The treatment of choice is surgical with low recurrence, usually attributed to incomplete resection.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors and reviewers must disclose any financial, professional, or personal conflicts of interest that could influence the results or interpretations of the work. This information will be treated confidentially and disclosed only as necessary to ensure transparency and impartiality in the publication process.
Copyright
RBPS adheres to the CC-BY-NC 4.0 license, meaning authors retain copyright of their work submitted to the journal.
- Originality Declaration: Authors must declare that their submission is original, has not been previously published, and is not under review elsewhere.
- Publication Rights: Upon submission, authors grant RBPS the exclusive right of first publication, subject to peer review.
- Additional Agreements: Authors may enter into non-exclusive agreements for the distribution of the RBPS-published version (e.g., in institutional repositories or as book chapters), provided the original authorship and publication by RBPS are acknowledged.
Authors are encouraged to share their work online (e.g., institutional repositories or personal websites) after initial publication in RBPS, with appropriate citation of authorship and original publication.
Under the CC-BY-NC 4.0 license, readers have the rights to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material.
These rights cannot be revoked, provided the following terms are met:
- Attribution: Proper credit must be given, a link to the license provided, and any changes clearly indicated.
- Non-Commercial: The material cannot be used for commercial purposes.
- No Additional Restrictions: No legal or technological measures may be applied to restrict others from doing anything the license permits.